Xinglan He

494 total citations
16 papers, 360 citations indexed

About

Xinglan He is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Xinglan He has authored 16 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Xinglan He's work include Systemic Sclerosis and Related Diseases (5 papers), Fibroblast Growth Factor Research (3 papers) and Connective Tissue Growth Factor Research (2 papers). Xinglan He is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Fibroblast Growth Factor Research (3 papers) and Connective Tissue Growth Factor Research (2 papers). Xinglan He collaborates with scholars based in China. Xinglan He's co-authors include Xiaolong Lin, Kai Zhang, Shuang Li, Zuo Wang, Xiaofeng Ma, Yue Zhao, Rong Xiao, Yangfan Xiao, Zhuotong Zeng and Yi Zhan and has published in prestigious journals such as Environmental Pollution, Frontiers in Immunology and Life Sciences.

In The Last Decade

Xinglan He

16 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinglan He China 7 231 119 63 55 33 16 360
Zilong Li China 12 193 0.8× 101 0.8× 76 1.2× 55 1.0× 44 1.3× 20 380
Zhonggai Chen China 9 155 0.7× 54 0.5× 47 0.7× 65 1.2× 34 1.0× 9 357
Francis Migneault Canada 10 250 1.1× 94 0.8× 99 1.6× 74 1.3× 27 0.8× 13 393
Shih‐Yen Weng Taiwan 8 159 0.7× 112 0.9× 96 1.5× 31 0.6× 43 1.3× 14 428
Chuanfu Li United States 5 197 0.9× 56 0.5× 79 1.3× 108 2.0× 28 0.8× 7 403
Zurong Fu China 7 248 1.1× 36 0.3× 74 1.2× 71 1.3× 38 1.2× 8 389
Sipin Tan China 14 336 1.5× 81 0.7× 96 1.5× 61 1.1× 54 1.6× 40 510
Amruta Singh India 8 200 0.9× 78 0.7× 32 0.5× 51 0.9× 11 0.3× 11 284
Geer Tian China 10 199 0.9× 43 0.4× 41 0.7× 49 0.9× 36 1.1× 17 358

Countries citing papers authored by Xinglan He

Since Specialization
Citations

This map shows the geographic impact of Xinglan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinglan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinglan He more than expected).

Fields of papers citing papers by Xinglan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinglan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinglan He. The network helps show where Xinglan He may publish in the future.

Co-authorship network of co-authors of Xinglan He

This figure shows the co-authorship network connecting the top 25 collaborators of Xinglan He. A scholar is included among the top collaborators of Xinglan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinglan He. Xinglan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhang, Haoqing, Xinglan He, Y Wang, et al.. (2024). Simultaneous CNV-seq and WES: An effective strategy for molecular diagnosis of unexplained fetal structural anomalies. Heliyon. 10(20). e39392–e39392. 1 indexed citations
2.
Tang, Rui, Xinglan He, Yaqian Shi, et al.. (2024). MiR-4769-3p suppresses adipogenesis in systemic sclerosis by negatively regulating the USP18/VDAC2 pathway. iScience. 27(8). 110483–110483. 1 indexed citations
3.
Shi, Yaqian, Zhuotong Zeng, Xinglan He, et al.. (2024). Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway. Environmental Pollution. 355. 124194–124194. 2 indexed citations
4.
He, Xinglan, et al.. (2024). Matrine Enhances the Antitumor Efficacy of Chidamide in CTCL by Promoting Apoptosis. Recent Patents on Anti-Cancer Drug Discovery. 20(2). 223–231. 2 indexed citations
5.
He, Xinglan, et al.. (2024). m6A RNA methylation: The latent string-puller in fibrosis. Life Sciences. 346. 122644–122644. 1 indexed citations
6.
Xiao, Yangfan, Xinglan He, Rui Tang, et al.. (2023). ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis. International Immunopharmacology. 121. 110420–110420. 1 indexed citations
7.
Zeng, Zhuotong, Yaoyao Wang, Yangfan Xiao, et al.. (2022). Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling. Arthritis Research & Therapy. 24(1). 50–50. 7 indexed citations
8.
He, Xinglan, Yaqian Shi, Zhuotong Zeng, et al.. (2022). Intimate intertwining of the pathogenesis of hypoxia and systemic sclerosis: A transcriptome integration analysis. Frontiers in Immunology. 13. 929289–929289. 4 indexed citations
9.
He, Xinglan, et al.. (2022). Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Frontiers in Immunology. 13. 841732–841732. 86 indexed citations
10.
Qu, Kai, et al.. (2017). Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway. Lipids in Health and Disease. 16(1). 223–223. 5 indexed citations
11.
Qu, Kai, Xinglan He, Hai Zhang, et al.. (2016). H2S inhibits apo(a) expression and secretion through PKCα/FXR and Akt/HNF4α pathways in HepG2 cells. Cell Biology International. 40(8). 906–916. 3 indexed citations
12.
Li, Guohua, Xiaolong Lin, Hai Zhang, et al.. (2015). Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1–AMPK–mTOR pathway. Atherosclerosis. 243(1). 223–235. 34 indexed citations
13.
Qu, Kai, Wang Zuo, Xiaolong Lin, et al.. (2015). MicroRNAs: Key regulators of endothelial progenitor cell functions. Clinica Chimica Acta. 448. 65–73. 43 indexed citations
14.
Lin, Xiaolong, et al.. (2014). FGF21 Increases Cholesterol Efflux by Upregulating ABCA1 Through the ERK1/2–PPARγ–LXRα Pathway in THP1 Macrophage-Derived Foam Cells. DNA and Cell Biology. 33(8). 514–521. 35 indexed citations
15.
Lin, Xiaolong, Guohua Li, Xinglan He, et al.. (2014). FGF21 inhibits apolipoprotein(a) expression in HepG2 cells via the FGFR1-ERK1/2-Elk-1 pathway. Molecular and Cellular Biochemistry. 393(1-2). 33–42. 10 indexed citations
16.
Lin, Xiaolong, Shuang Li, Yue Zhao, et al.. (2013). Interaction Domains of p62: A Bridge Between p62 and Selective Autophagy. DNA and Cell Biology. 32(5). 220–227. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zilong Li Breakdown of academic impact, for papers by Zhonggai Chen Breakdown of academic impact, for papers by Francis Migneault Breakdown of academic impact, for papers by Shih‐Yen Weng Breakdown of academic impact, for papers by Chuanfu Li Breakdown of academic impact, for papers by Zurong Fu Breakdown of academic impact, for papers by Sipin Tan Breakdown of academic impact, for papers by Amruta Singh Breakdown of academic impact, for papers by Geer Tian
Rankless by CCL
2026